Annual Operating Profit
$1.48 B
-$248.50 M-14.38%
December 1, 2024
Summary
- As of February 25, 2025, EW annual operating income is $1.48 billion, with the most recent change of -$248.50 million (-14.38%) on December 1, 2024.
- During the last 3 years, EW annual operating profit has fallen by -$106.70 million (-6.72%).
- EW annual operating profit is now -17.28% below its all-time high of $1.79 billion, reached on December 31, 2022.
Performance
EW Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$353.30 M
-$41.00 M-10.40%
December 1, 2024
Summary
- As of February 25, 2025, EW quarterly operating income is $353.30 million, with the most recent change of -$41.00 million (-10.40%) on December 1, 2024.
- Over the past year, EW quarterly operating profit has dropped by -$41.00 million (-10.40%).
- EW quarterly operating profit is now -41.03% below its all-time high of $599.10 million, reached on December 31, 2023.
Performance
EW Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$1.56 B
-$245.80 M-13.59%
December 1, 2024
Summary
- As of February 25, 2025, EW TTM operating income is $1.56 billion, with the most recent change of -$245.80 million (-13.59%) on December 1, 2024.
- Over the past year, EW TTM operating profit has dropped by -$245.80 million (-13.59%).
- EW TTM operating profit is now -13.59% below its all-time high of $1.81 billion, reached on September 30, 2024.
Performance
EW TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
EW Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.4% | -10.4% | -13.6% |
| 3 y3 years | -6.7% | -10.4% | -13.6% |
| 5 y5 years | +19.5% | -10.4% | -13.6% |
EW Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.3% | at low | -41.0% | at low | -13.6% | at low |
| 5 y | 5-year | -17.3% | +19.5% | -41.0% | +53.7% | -13.6% | +26.1% |
| alltime | all time | -17.3% | +6041.5% | -41.0% | +762.9% | -13.6% | +6383.4% |
Edwards Lifesciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.48 B(-14.4%) | $353.30 M(-10.4%) | $1.56 B(-13.6%) |
| Sep 2024 | - | $394.30 M(+4.5%) | $1.81 B(+1.5%) |
| Jun 2024 | - | $377.20 M(-13.8%) | $1.78 B(-0.4%) |
| Mar 2024 | - | $437.70 M(-26.9%) | $1.79 B(+0.3%) |
| Dec 2023 | $1.73 B(-3.4%) | $599.10 M(+62.8%) | $1.78 B(+9.3%) |
| Sep 2023 | - | $368.10 M(-4.3%) | $1.63 B(-5.0%) |
| Jun 2023 | - | $384.50 M(-11.1%) | $1.72 B(-3.4%) |
| Mar 2023 | - | $432.60 M(-3.3%) | $1.78 B(-0.6%) |
| Dec 2022 | $1.79 B(+12.8%) | $447.20 M(-1.6%) | $1.79 B(+4.9%) |
| Sep 2022 | - | $454.30 M(+2.2%) | $1.71 B(+3.5%) |
| Jun 2022 | - | $444.70 M(+0.4%) | $1.65 B(+0.2%) |
| Mar 2022 | - | $443.00 M(+21.9%) | $1.64 B(+3.6%) |
| Dec 2021 | $1.59 B(+20.5%) | $363.40 M(-8.3%) | $1.59 B(+0.1%) |
| Sep 2021 | - | $396.10 M(-10.4%) | $1.58 B(+2.5%) |
| Jun 2021 | - | $441.90 M(+14.7%) | $1.55 B(+15.9%) |
| Mar 2021 | - | $385.40 M(+6.7%) | $1.33 B(+1.3%) |
| Dec 2020 | $1.32 B(+6.3%) | $361.20 M(+1.1%) | $1.32 B(+1.1%) |
| Sep 2020 | - | $357.20 M(+55.4%) | $1.30 B(+4.6%) |
| Jun 2020 | - | $229.80 M(-37.6%) | $1.24 B(-4.1%) |
| Mar 2020 | - | $368.40 M(+6.2%) | $1.30 B(+4.8%) |
| Dec 2019 | $1.24 B(+15.5%) | $346.80 M(+15.6%) | $1.24 B(+4.6%) |
| Sep 2019 | - | $299.90 M(+6.2%) | $1.18 B(+4.4%) |
| Jun 2019 | - | $282.50 M(-8.7%) | $1.13 B(+1.2%) |
| Mar 2019 | - | $309.50 M(+6.1%) | $1.12 B(+4.4%) |
| Dec 2018 | $1.07 B(+5.6%) | $291.80 M(+16.5%) | $1.07 B(+5.7%) |
| Sep 2018 | - | $250.40 M(-6.7%) | $1.01 B(+3.0%) |
| Jun 2018 | - | $268.50 M(+2.5%) | $985.00 M(+1.7%) |
| Mar 2018 | - | $262.00 M(+12.1%) | $968.30 M(-4.7%) |
| Dec 2017 | $1.02 B(+29.4%) | $233.80 M(+5.9%) | $1.02 B(+2.8%) |
| Sep 2017 | - | $220.70 M(-12.4%) | $988.10 M(+2.6%) |
| Jun 2017 | - | $251.80 M(-18.7%) | $962.80 M(+7.9%) |
| Mar 2017 | - | $309.60 M(+50.3%) | $892.00 M(+13.6%) |
| Dec 2016 | $784.90 M(+22.1%) | $206.00 M(+5.4%) | $784.90 M(+4.1%) |
| Sep 2016 | - | $195.40 M(+8.0%) | $753.80 M(+5.5%) |
| Jun 2016 | - | $181.00 M(-10.6%) | $714.20 M(+5.0%) |
| Mar 2016 | - | $202.50 M(+15.8%) | $680.00 M(+5.8%) |
| Dec 2015 | $642.90 M(+33.2%) | $174.90 M(+12.3%) | $642.90 M(+5.7%) |
| Sep 2015 | - | $155.80 M(+6.1%) | $608.30 M(+4.5%) |
| Jun 2015 | - | $146.80 M(-11.2%) | $582.00 M(+5.0%) |
| Mar 2015 | - | $165.40 M(+17.9%) | $554.50 M(+14.9%) |
| Dec 2014 | $482.60 M(+2.1%) | $140.30 M(+8.3%) | $482.60 M(+2.8%) |
| Sep 2014 | - | $129.50 M(+8.5%) | $469.30 M(+5.4%) |
| Jun 2014 | - | $119.30 M(+27.6%) | $445.30 M(-1.6%) |
| Mar 2014 | - | $93.50 M(-26.4%) | $452.50 M(-4.2%) |
| Dec 2013 | $472.50 M(+12.5%) | $127.00 M(+20.4%) | $472.50 M(-3.4%) |
| Sep 2013 | - | $105.50 M(-16.6%) | $488.90 M(+2.3%) |
| Jun 2013 | - | $126.50 M(+11.5%) | $478.00 M(+6.9%) |
| Mar 2013 | - | $113.50 M(-20.9%) | $447.30 M(+6.5%) |
| Dec 2012 | $419.90 M | $143.40 M(+51.6%) | $419.90 M(+15.7%) |
| Sep 2012 | - | $94.60 M(-1.3%) | $363.00 M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $95.80 M(+11.3%) | $328.30 M(+6.7%) |
| Mar 2012 | - | $86.10 M(-0.5%) | $307.80 M(+2.6%) |
| Dec 2011 | $300.10 M(+5.6%) | $86.50 M(+44.4%) | $300.10 M(+2.0%) |
| Sep 2011 | - | $59.90 M(-20.5%) | $294.20 M(-2.5%) |
| Jun 2011 | - | $75.30 M(-4.0%) | $301.70 M(+0.6%) |
| Mar 2011 | - | $78.40 M(-2.7%) | $300.00 M(+5.5%) |
| Dec 2010 | $284.30 M(+19.5%) | $80.60 M(+19.6%) | $284.30 M(+6.0%) |
| Sep 2010 | - | $67.40 M(-8.4%) | $268.10 M(+4.3%) |
| Jun 2010 | - | $73.60 M(+17.4%) | $257.10 M(+4.5%) |
| Mar 2010 | - | $62.70 M(-2.6%) | $246.00 M(+3.4%) |
| Dec 2009 | $238.00 M(+20.0%) | $64.40 M(+14.2%) | $238.00 M(+4.2%) |
| Sep 2009 | - | $56.40 M(-9.8%) | $228.50 M(+5.6%) |
| Jun 2009 | - | $62.50 M(+14.3%) | $216.40 M(+4.7%) |
| Mar 2009 | - | $54.70 M(-0.4%) | $206.60 M(+4.2%) |
| Dec 2008 | $198.30 M(+14.9%) | $54.90 M(+23.9%) | $198.30 M(+5.0%) |
| Sep 2008 | - | $44.30 M(-15.9%) | $188.80 M(+4.3%) |
| Jun 2008 | - | $52.70 M(+13.6%) | $181.10 M(+3.2%) |
| Mar 2008 | - | $46.40 M(+2.2%) | $175.50 M(+1.0%) |
| Dec 2007 | $172.60 M(-0.3%) | $45.40 M(+24.0%) | $173.70 M(+1.3%) |
| Sep 2007 | - | $36.60 M(-22.3%) | $171.40 M(-2.1%) |
| Jun 2007 | - | $47.10 M(+5.6%) | $175.00 M(+0.8%) |
| Mar 2007 | - | $44.60 M(+3.5%) | $173.60 M(-11.0%) |
| Dec 2006 | $173.20 M(-1.2%) | $43.10 M(+7.2%) | $195.00 M(-1.9%) |
| Sep 2006 | - | $40.20 M(-12.0%) | $198.80 M(+0.1%) |
| Jun 2006 | - | $45.70 M(-30.8%) | $198.70 M(-0.2%) |
| Mar 2006 | - | $66.00 M(+40.7%) | $199.00 M(+13.3%) |
| Dec 2005 | $175.30 M(+13.5%) | $46.90 M(+17.0%) | $175.60 M(+4.2%) |
| Sep 2005 | - | $40.10 M(-12.8%) | $168.50 M(+2.9%) |
| Jun 2005 | - | $46.00 M(+8.0%) | $163.70 M(+3.5%) |
| Mar 2005 | - | $42.60 M(+7.0%) | $158.20 M(+13.8%) |
| Dec 2004 | $154.40 M(+11.6%) | $39.80 M(+12.7%) | $139.00 M(+0.5%) |
| Sep 2004 | - | $35.30 M(-12.8%) | $138.30 M(+2.5%) |
| Jun 2004 | - | $40.50 M(+73.1%) | $134.90 M(+7.5%) |
| Mar 2004 | - | $23.40 M(-40.2%) | $125.50 M(-7.1%) |
| Dec 2003 | $138.40 M(+165.6%) | $39.10 M(+22.6%) | $135.10 M(+6.4%) |
| Sep 2003 | - | $31.90 M(+2.6%) | $127.00 M(+134.3%) |
| Jun 2003 | - | $31.10 M(-5.8%) | $54.20 M(0.0%) |
| Mar 2003 | - | $33.00 M(+6.5%) | $54.20 M(+4.0%) |
| Dec 2002 | $52.10 M(+116.2%) | $31.00 M(-175.8%) | $52.10 M(+8.1%) |
| Sep 2002 | - | -$40.90 M(-231.5%) | $48.20 M(-57.1%) |
| Jun 2002 | - | $31.10 M(+0.6%) | $112.40 M(+301.4%) |
| Mar 2002 | - | $30.90 M(+14.0%) | $28.00 M(+16.2%) |
| Dec 2001 | $24.10 M(-74.6%) | $27.10 M(+16.3%) | $24.10 M(-44.0%) |
| Sep 2001 | - | $23.30 M(-143.7%) | $43.00 M(-2.3%) |
| Jun 2001 | - | -$53.30 M(-297.4%) | $44.00 M(-58.2%) |
| Mar 2001 | - | $27.00 M(-41.3%) | $105.30 M(+1.9%) |
| Dec 2000 | $95.00 M(-18.8%) | $46.00 M(+89.3%) | $103.30 M(+80.3%) |
| Sep 2000 | - | $24.30 M(+203.8%) | $57.30 M(+73.6%) |
| Jun 2000 | - | $8.00 M(-68.0%) | $33.00 M(+32.0%) |
| Mar 2000 | - | $25.00 M | $25.00 M |
| Dec 1999 | $117.00 M | - | - |
FAQ
- What is Edwards Lifesciences annual operating income?
- What is the all time high annual operating profit for Edwards Lifesciences?
- What is Edwards Lifesciences annual operating profit year-on-year change?
- What is Edwards Lifesciences quarterly operating income?
- What is the all time high quarterly operating profit for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly operating profit year-on-year change?
- What is Edwards Lifesciences TTM operating income?
- What is the all time high TTM operating profit for Edwards Lifesciences?
- What is Edwards Lifesciences TTM operating profit year-on-year change?
What is Edwards Lifesciences annual operating income?
The current annual operating profit of EW is $1.48 B
What is the all time high annual operating profit for Edwards Lifesciences?
Edwards Lifesciences all-time high annual operating income is $1.79 B
What is Edwards Lifesciences annual operating profit year-on-year change?
Over the past year, EW annual operating income has changed by -$248.50 M (-14.38%)
What is Edwards Lifesciences quarterly operating income?
The current quarterly operating profit of EW is $353.30 M
What is the all time high quarterly operating profit for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly operating income is $599.10 M
What is Edwards Lifesciences quarterly operating profit year-on-year change?
Over the past year, EW quarterly operating income has changed by -$41.00 M (-10.40%)
What is Edwards Lifesciences TTM operating income?
The current TTM operating profit of EW is $1.56 B
What is the all time high TTM operating profit for Edwards Lifesciences?
Edwards Lifesciences all-time high TTM operating income is $1.81 B
What is Edwards Lifesciences TTM operating profit year-on-year change?
Over the past year, EW TTM operating income has changed by -$245.80 M (-13.59%)